Education
Validity and utility of the PRIME-MD Patient Health Questionnaire in assessment of 3000 obstetric-gynecologic patients: The PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study,☆☆,

https://doi.org/10.1067/mob.2000.106580Get rights and content
Under a Creative Commons license
open archive

Abstract

Objective: This study was undertaken to determine the prevalence of mental disorders among obstetric-gynecologic patients and to assess the validity and utility of the PRIME-MD Patient Health Questionnaire (PHQ) in this population. Study Design: A total of 3000 patients were assessed by 63 clinicians at seven obstetrics-gynecology outpatient care sites. The main outcome measures were PRIME-MD PHQ diagnoses, psychosocial stressors, independent diagnoses made by mental health professionals, functional status measures, disability days, health care use, and treatment or referral decisions. Results: Current mental disorders were fairly prevalent, present in 1 in 5 obstetric-gynecologic patients. Patients with PRIME-MD PHQ diagnoses had more functional impairment, disability days, health care use, and psychosocial stressors than did patients without PRIME-MD PHQ diagnoses (P <.005 for all measures). Although most clinicians judged the PRIME-MD PHQ to be useful in management decisions, the questionnaire diagnosis of mental disorder rarely led to therapeutic intervention. Conclusion: The PRIME-MD PHQ is a useful instrument for the assessment of mental disorders, functional impairment, and recent psychosocial stressors in the busy obstetrics-gynecology setting. (Am J Obstet Gynecol 2000;183:759-69.)

Keywords

Mental disorders
obstetrics-gynecology
PRIME-MD
PRIME-MD Patient Health Questionnaire
PRIME-MD PHQ

Cited by (0)

The development of the PRIME-MD Patient Health Questionnaire was underwritten by an educational grant from Pfizer US Pharmaceuticals Inc, New York, NY.

☆☆

PRIME-MD is a trademark of Pfizer Inc, New York, NY.

Reprint requests: Robert L. Spitzer, MD, Biometrics Research Department, New York State Psychiatric Institute, Unit 60, 1051 Riverside Dr, New York, NY, 10032. For a complimentary copy of reproducible PRIME-MD Patient Health Questionnaire materials, e-mail Robert L. Spitzer, MD, at [email protected].